Arax Advisory Partners’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$160K Buy
7,811
+7,412
+1,858% +$170K ﹤0.01% 2402
2026
Q1
$8.79K Buy
399
+32
+9% +$557 ﹤0.01% 2514
2025
Q4
$4.33K Buy
367
+125
+52% +$1.6K ﹤0.01% 2930
2025
Q3
$3.83K Sell
242
-640
-73% -$9.28K ﹤0.01% 2950
2025
Q2
$10.4K Buy
882
+609
+223% +$6.86K ﹤0.01% 1945
2025
Q1
$3.69K Sell
273
-22
-7% -$365 ﹤0.01% 1885
2024
Q4
$4.99K Buy
+295
New +$5.74K ﹤0.01% 1744
2020
Q2
Sell
-8,000
Closed -$71K 680
2020
Q1
$71K Buy
+8,000
New +$115K 0.02% 283

Other funds holding CC

Arax Advisory Partners's CC Position: Q2 2026 in Review

Arax Advisory Partners increased its Chemours (CC) stake by 1,858% in Q2 2026, buying an estimated $170K and bringing the position to 7,811 shares worth $160K. The position accounts for ﹤0.01% of the portfolio, ranked #2402.

Arax Advisory Partners first reported a position in CC in Q1 2020 and has held it in 8 quarters since. 470 funds tracked by Wall St. Rank hold CC as of Q2 2026.

  • Arax Advisory Partners held 7,811 shares of Chemours worth $160K as of Q2 2026.
  • Arax Advisory Partners bought 7,412 Chemours shares in Q2 2026, an estimated $170K.
  • Chemours made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #2402 holding.
  • Arax Advisory Partners first reported a position in Chemours in Q1 2020 and has held it in 8 quarters since.
  • 470 funds tracked by Wall St. Rank held Chemours as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.